0001650840-23-000004.txt : 20231122
0001650840-23-000004.hdr.sgml : 20231122
20231122163734
ACCESSION NUMBER: 0001650840-23-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20231122
DATE AS OF CHANGE: 20231122
EFFECTIVENESS DATE: 20231122
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerami Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001650840
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-498010
FILM NUMBER: 231433997
BUSINESS ADDRESS:
STREET 1: 2520 MERIDIAN PARKWAY
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 9195897495
MAIL ADDRESS:
STREET 1: 2520 MERIDIAN PARKWAY
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: Dance Biopharm Holdings, Inc.
DATE OF NAME CHANGE: 20150819
FORMER COMPANY:
FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc.
DATE OF NAME CHANGE: 20150812
D
1
primary_doc.xml
X0708
D
LIVE
0001650840
Aerami Therapeutics Holdings, Inc.
600 Park Offices Dr.
Ste. 300
Durham
NC
NORTH CAROLINA
27709
919-797-9792
DELAWARE
SAV Holdings Corp.
Dance Biopharm Holdings, Inc.
Dance BioPharm Holdings, Inc.
Corporation
true
Anne
C.
Whitaker
600 Park Offices Dr.
Ste. 300
Durham
NC
NORTH CAROLINA
27709
Executive Officer
Director
Chief Executive Officer, Chairwoman of the Board
Darlene
Deptula-Hicks
600 Park Offices Dr.
Ste. 300
Durham
NC
NORTH CAROLINA
27709
Executive Officer
Director
Chief Financial Officer and Director
Steven
Thornton
600 Park Offices Dr.
Ste. 300
Durham
NC
NORTH CAROLINA
27709
Director
Adam
K.
Stern
600 Park Offices Dr.
Ste. 300
Durham
NC
NORTH CAROLINA
27709
Director
William
Patrick
Welch
600 Park Offices Dr.
Ste. 300
Durham
NC
NORTH CAROLINA
27709
Director
John
S.
Patton
600 Park Offices Dr.
Ste. 300
Durham
NC
NORTH CAROLINA
27709
Director
Joshua
Ziel
600 Park Offices Dr.
Ste. 300
Durham
NC
NORTH CAROLINA
27709
Executive Officer
Chief Operating Officer
Gary
C.
Burgess
600 Park Offices Dr.
Ste. 300
Durham
NC
NORTH CAROLINA
27709
Executive Officer
Chief Medical Officer
Other Health Care
Decline to Disclose
- 06b
false
2023-11-09
false
true
true
false
0
Aegis Capital Corp.
15007
None
None
1345 Avenue of Americas
27th Fl.
New York
NY
NEW YORK
10105
AZ
ARIZONA
CA
CALIFORNIA
CO
COLORADO
FL
FLORIDA
IL
ILLINOIS
MD
MARYLAND
NV
NEVADA
NJ
NEW JERSEY
NY
NEW YORK
OR
OREGON
PA
PENNSYLVANIA
RI
RHODE ISLAND
SC
SOUTH CAROLINA
TN
TENNESSEE
TX
TEXAS
WV
WEST VIRGINIA
WI
WISCONSIN
true
20000000
1016000
18984000
The maximum offering amount is $10,000,000. If the offering is oversubscribed issuer and placement agent may at their mutual discretion have the issuer offer up to an additional $10,000,000 principal amount. The note offering will last until 1/3/2024.
false
30
94000
0
The placement agent will also be issued warrants to purchase up to 10% of the number of shares of capital stock issuable upon the conversion of the Notes following the final closing of the note offering.
0
Proceeds to be used for general working capital as necessary, including strategic transaction opportunities, if any. A portion of proceeds will compensate the placement agent. Adam K. Stern, a director of issuer, is an affiliate of the placement agent.
false
Aerami Therapeutics Holdings, Inc.
Darlene Deptula-Hicks
Darlene Deptula-Hicks
Chief Financial Officer
2023-11-22